Cargando…

No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease

Detalles Bibliográficos
Autores principales:	Biquard, Louise, Valla, Dominique, Rautou, Pierre-Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191298/ https://www.ncbi.nlm.nih.gov/pubmed/32360995 http://dx.doi.org/10.1016/j.jhep.2020.04.035

Ejemplares similares

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Metabolic Phenotypes: Drivers of Health Outcomes in Fatty Liver Diseases
por: Charatcharoenwitthaya, Phunchai
Publicado: (2023)

Lack of genetic evidence that fatty liver disease predisposes to COVID-19
por: Valenti, Luca, et al.
Publicado: (2020)

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
por: Targher, G., et al.
Publicado: (2020)

Acute Fatty Liver of Pregnancy
por: Dey, Madhusudan, et al.
Publicado: (2012)

Utilization of SARS-COV-2 positive donors and recipients for liver transplantation in the pandemic era – An evidence-based review
por: Agrawal, Dhiraj, et al.
Publicado: (2022)

Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma
por: Souhami, Alexandra, et al.
Publicado: (2020)

The present evidence summary of SARS-CoV-2 vaccine-associated liver injury: A rapid systematic review
por: Li, Zheng, et al.
Publicado: (2023)

Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
por: Abbas, Tahany, et al.
Publicado: (2020)

Fructoholism in adults: The importance of personalised care in metabolic dysfunction-associated fatty liver disease
por: Salavrakos, Mélissa, et al.
Publicado: (2021)

Liver Autophagy in Anorexia Nervosa and Acute Liver Injury
por: Kheloufi, Marouane, et al.
Publicado: (2014)

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient
por: Dumortier, Jérôme
Publicado: (2022)

Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
por: Giabicani, Mikhael, et al.
Publicado: (2022)

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
por: Ali, Nurshad
Publicado: (2020)

SARS-CoV-2: Is the liver merely a bystander to severe disease?
por: Bangash, Mansoor N., et al.
Publicado: (2020)

SARS-CoV-2 related liver impairment – perception may not be the reality
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Unexplained liver test elevations after SARS-CoV-2 vaccination
por: Guardiola, John, et al.
Publicado: (2022)

Liver- Heart Inter- Relationship in Fatty Liver Disease Based on the Avicenna’s Point of View
por: KHADEM, Ebrahim, et al.
Publicado: (2013)

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
por: Guarino, Maria, et al.
Publicado: (2022)

SARS-CoV-2 infection in liver transplant recipients: A complex relationship
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021)

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients
por: Garg, Vivek Kumar, et al.
Publicado: (2018)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Poor Response to Inactivated SARS-CoV-2 Vaccine in Patients With Chronic Liver Disease
por: Cao, Huanhuan, et al.
Publicado: (2022)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Revised Nomenclature for Fatty Liver Disease: Cutting through the Confusion
por: Alsawat, Khalid, et al.
Publicado: (2020)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine
por: Kim, Hyun Young, et al.
Publicado: (2022)

USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS
por: Villar, Livia Melo, et al.
Publicado: (2021)

Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection
por: Nayagam, Jeremy S, et al.
Publicado: (2021)

SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted
por: Verma, Henu Kumar, et al.
Publicado: (2021)

Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
por: Lee, Soon Kyu, et al.
Publicado: (2022)

Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures
por: Bissonnette, Julien, et al.
Publicado: (2022)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uro4286nt341gb1esvvmse9unq